お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、オリゴヌクレオチドの合成の世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にオリゴヌクレオチドの合成市場を分類しています。
本レポートでは世界のオリゴヌクレオチドの合成市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Thermo Fisher Scientific、Merck、Azenta Life Sciences、BBI Life Sciences、TriLink BioTechnologies、Aurigene Pharmaceutical Services、Integrated DNA Technologies (IDT)、Cusabio、Macrogen、Synbio Technologies、Eurogentec、Genscript、Abace Biotechnology、Tsingke、Guangzhou RiboBio、Atantares、Wuhan GeneCreate Biological Engineering、Beyotime、General Biol、Biosune

レポートはオリゴヌクレオチドの合成の主要生産者を調査し、主要地域や国の消費状況も提供します。オリゴヌクレオチドの合成の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Common Primer Synthesis
    Modified Primer Synthesis

用途別の市場セグメント：
    Biotech Company
    Academic Scientific Research Institution

本レポートの詳細内容
本レポートは、世界のオリゴヌクレオチドの合成市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてオリゴヌクレオチドの合成市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）のオリゴヌクレオチドの合成生産量、成長率、市場シェアを調査している。

二. 消費面では、オリゴヌクレオチドの合成の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーのオリゴヌクレオチドの合成売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界のオリゴヌクレオチドの合成市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本オリゴヌクレオチドの合成のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：オリゴヌクレオチドの合成のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： オリゴヌクレオチドの合成の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおけるオリゴヌクレオチドの合成の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章オリゴヌクレオチドの合成メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：オリゴヌクレオチドの合成の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：オリゴヌクレオチドの合成の主要メーカーの概要を提供し、製品の説明と仕様、オリゴヌクレオチドの合成の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：オリゴヌクレオチドの合成の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Valued at US$ 773 million in 2024, the global Oligo Synthesis market is forecast to reach US$ 1492 million by 2030, at a CAGR of 11.6% during the forecast period.
Oligo synthesis, also known as oligonucleotide synthesis, is a laboratory technique used to chemically synthesize short sequences of nucleic acids, typically DNA or RNA oligonucleotides. These oligonucleotides are composed of relatively short chains of nucleotides, usually less than 100 bases in length. Oligos (or oligonucleotides) are commonly used as primers in PCR (polymerase chain reactions) to selectively amplify target DNA sequences. They can be tagged with fluorescent dyes or radioisotopes for detection purposes. Oligos are often used in DNA sequencing, gene synthesis, and genetic testing, and can be modified for gene therapies or gene expression.
Global key players of Oligo Synthesis include Thermo Fisher Scientific, Merck, Genscript, BBI Life Sciences, Integrated DNA Technologies (IDT), etc. The top five players hold a share about 44%. North America is the largest market, and has a share about 53%, followed by Asia-Pacific and Europe with share 25% and 15%, separately. In terms of product type, Common Primer Synthesis is the largest segment, occupied for a share of 64%. In terms of end user, Biotech Company has a share about 75 percent.
Report Includes
This report presents an overview of global market for Oligo Synthesis market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Oligo Synthesis, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Oligo Synthesis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oligo Synthesis revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Oligo Synthesis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by End User, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Oligo Synthesis revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Thermo Fisher Scientific, Merck, Azenta Life Sciences, BBI Life Sciences, TriLink BioTechnologies, Aurigene Pharmaceutical Services, Integrated DNA Technologies (IDT), Cusabio, Macrogen, Synbio Technologies, etc.

Market Segmentation
By Company
    Thermo Fisher Scientific
    Merck
    Azenta Life Sciences
    BBI Life Sciences
    TriLink BioTechnologies
    Aurigene Pharmaceutical Services
    Integrated DNA Technologies (IDT)
    Cusabio
    Macrogen
    Synbio Technologies
    Eurogentec
    Genscript
    Abace Biotechnology
    Tsingke
    Guangzhou RiboBio
    Atantares
    Wuhan GeneCreate Biological Engineering
    Beyotime
    General Biol
    Biosune

Segment by Type
    Common Primer Synthesis
    Modified Primer Synthesis

Segment by End User
    Biotech Company
    Academic Scientific Research Institution

By Region
    North America
        United States
        Canada
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Latin America
        Mexico
        Brazil
        Rest of South America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Oligo Synthesis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oligo Synthesis companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End User, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by End User and by country, revenue for each segment.
Chapter 7: Europe by Type, by End User and by country, revenue for each segment.
Chapter 8: China by Type, and by End User, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by End User and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by End User and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oligo Synthesis revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
 Table 1. Global Oligo Synthesis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Common Primer Synthesis
 Table 3. Key Players of Modified Primer Synthesis
 Table 4. Global Oligo Synthesis Market Size Growth by End User (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Oligo Synthesis Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Market Size by Region (2020-2031) & (US$ Million)
 Table 7. Global Oligo Synthesis Market Share by Region (2020-2031)
 Table 8. Market Trends
 Table 9. Market Drivers
 Table 10. Market Challenges
 Table 11. Market Restraints
 Table 12. Global Oligo Synthesis Revenue by Players (2020-2025) & (US$ Million)
 Table 13. Global Oligo Synthesis Market Share by Players (2020-2025)
 Table 14. Global Top Oligo Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligo Synthesis as of 2024)
 Table 15. Global Oligo Synthesis Industry Ranking 2023 VS 2024
 Table 16. Global 5 Largest Players Market Share by Oligo Synthesis Revenue (CR5 and HHI) & (2020-2025)
 Table 17. Global Key Players of Oligo Synthesis, Headquarters and Area Served
 Table 18. Global Key Players of Oligo Synthesis, Product and Application
 Table 19. Global Key Players of Oligo Synthesis, Date of Enter into This Industry
 Table 20. Mergers & Acquisitions, Expansion Plans
 Table 21. Global Market Size by Type (2020-2025) & (US$ Million)
 Table 22. Global Oligo Synthesis Revenue Market Share by Type (2020-2025)
 Table 23. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 24. Global Oligo Synthesis Revenue Market Share by Type (2026-2031)
 Table 25. Global Market Size by End User (2020-2025) & (US$ Million)
 Table 26. Global Oligo Synthesis Revenue Market Share by End User (2020-2025)
 Table 27. Global Forecasted Market Size by End User (2026-2031) & (US$ Million)
 Table 28. Global Oligo Synthesis Revenue Market Share by End User (2026-2031)
 Table 29. North America Market Size by Type (2020-2031) & (US$ Million)
 Table 30. North America Market Size by End User (2020-2031) & (US$ Million)
 Table 31. North America Oligo Synthesis Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Market Size by Country (2020-2031) & (US$ Million)
 Table 33. Europe Market Size by Type (2020-2031) & (US$ Million)
 Table 34. Europe Market Size by End User (2020-2031) & (US$ Million)
 Table 35. Europe Oligo Synthesis Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Market Size by Country (2020-2025) & (US$ Million)
 Table 37. China Market Size by Type (2020-2031) & (US$ Million)
 Table 38. China Market Size by End User (2020-2031) & (US$ Million)
 Table 39. Asia Market Size by Type (2020-2031) & (US$ Million)
 Table 40. Asia Market Size by End User (2020-2025) & (US$ Million)
 Table 41. Asia Oligo Synthesis Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia Market Size by Region (2020-2031) & (US$ Million)
 Table 43. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)
 Table 44. Middle East, Africa, and Latin America Market Size by End User (2020-2031) & (US$ Million)
 Table 45. Middle East, Africa, and Latin America Oligo Synthesis Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)
 Table 47. Thermo Fisher Scientific Company Details
 Table 48. Thermo Fisher Scientific Business Overview
 Table 49. Thermo Fisher Scientific Oligo Synthesis Product
 Table 50. Thermo Fisher Scientific Revenue (2020-2025) & (US$ Million)
 Table 51. Thermo Fisher Scientific Recent Development
 Table 52. Merck Company Details
 Table 53. Merck Business Overview
 Table 54. Merck Oligo Synthesis Product
 Table 55. Merck Revenue (2020-2025) & (US$ Million)
 Table 56. Merck Recent Development
 Table 57. Azenta Life Sciences Company Details
 Table 58. Azenta Life Sciences Business Overview
 Table 59. Azenta Life Sciences Oligo Synthesis Product
 Table 60. Azenta Life Sciences Revenue (2020-2025) & (US$ Million)
 Table 61. Azenta Life Sciences Recent Development
 Table 62. BBI Life Sciences Company Details
 Table 63. BBI Life Sciences Business Overview
 Table 64. BBI Life Sciences Oligo Synthesis Product
 Table 65. BBI Life Sciences Revenue (2020-2025) & (US$ Million)
 Table 66. BBI Life Sciences Recent Development
 Table 67. TriLink BioTechnologies Company Details
 Table 68. TriLink BioTechnologies Business Overview
 Table 69. TriLink BioTechnologies Oligo Synthesis Product
 Table 70. TriLink BioTechnologies Revenue (2020-2025) & (US$ Million)
 Table 71. TriLink BioTechnologies Recent Development
 Table 72. Aurigene Pharmaceutical Services Company Details
 Table 73. Aurigene Pharmaceutical Services Business Overview
 Table 74. Aurigene Pharmaceutical Services Oligo Synthesis Product
 Table 75. Aurigene Pharmaceutical Services Revenue (2020-2025) & (US$ Million)
 Table 76. Aurigene Pharmaceutical Services Recent Development
 Table 77. Integrated DNA Technologies (IDT) Company Details
 Table 78. Integrated DNA Technologies (IDT) Business Overview
 Table 79. Integrated DNA Technologies (IDT) Oligo Synthesis Product
 Table 80. Integrated DNA Technologies (IDT) Revenue (2020-2025) & (US$ Million)
 Table 81. Integrated DNA Technologies (IDT) Recent Development
 Table 82. Cusabio Company Details
 Table 83. Cusabio Business Overview
 Table 84. Cusabio Oligo Synthesis Product
 Table 85. Cusabio Revenue (2020-2025) & (US$ Million)
 Table 86. Cusabio Recent Development
 Table 87. Macrogen Company Details
 Table 88. Macrogen Business Overview
 Table 89. Macrogen Oligo Synthesis Product
 Table 90. Macrogen Revenue (2020-2025) & (US$ Million)
 Table 91. Macrogen Recent Development
 Table 92. Synbio Technologies Company Details
 Table 93. Synbio Technologies Business Overview
 Table 94. Synbio Technologies Oligo Synthesis Product
 Table 95. Synbio Technologies Revenue (2020-2025) & (US$ Million)
 Table 96. Synbio Technologies Recent Development
 Table 97. Eurogentec Company Details
 Table 98. Eurogentec Business Overview
 Table 99. Eurogentec Oligo Synthesis Product
 Table 100. Eurogentec Revenue (2020-2025) & (US$ Million)
 Table 101. Eurogentec Recent Development
 Table 102. Genscript Company Details
 Table 103. Genscript Business Overview
 Table 104. Genscript Oligo Synthesis Product
 Table 105. Genscript Revenue (2020-2025) & (US$ Million)
 Table 106. Genscript Recent Development
 Table 107. Abace Biotechnology Company Details
 Table 108. Abace Biotechnology Business Overview
 Table 109. Abace Biotechnology Oligo Synthesis Product
 Table 110. Abace Biotechnology Revenue (2020-2025) & (US$ Million)
 Table 111. Abace Biotechnology Recent Development
 Table 112. Tsingke Company Details
 Table 113. Tsingke Business Overview
 Table 114. Tsingke Oligo Synthesis Product
 Table 115. Tsingke Revenue (2020-2025) & (US$ Million)
 Table 116. Tsingke Recent Development
 Table 117. Guangzhou RiboBio Company Details
 Table 118. Guangzhou RiboBio Business Overview
 Table 119. Guangzhou RiboBio Oligo Synthesis Product
 Table 120. Guangzhou RiboBio Revenue (2020-2025) & (US$ Million)
 Table 121. Guangzhou RiboBio Recent Development
 Table 122. Atantares Company Details
 Table 123. Atantares Business Overview
 Table 124. Atantares Oligo Synthesis Product
 Table 125. Atantares Revenue (2020-2025) & (US$ Million)
 Table 126. Atantares Recent Development
 Table 127. Wuhan GeneCreate Biological Engineering Company Details
 Table 128. Wuhan GeneCreate Biological Engineering Business Overview
 Table 129. Wuhan GeneCreate Biological Engineering Oligo Synthesis Product
 Table 130. Wuhan GeneCreate Biological Engineering Revenue (2020-2025) & (US$ Million)
 Table 131. Wuhan GeneCreate Biological Engineering Recent Development
 Table 132. Beyotime Company Details
 Table 133. Beyotime Business Overview
 Table 134. Beyotime Oligo Synthesis Product
 Table 135. Beyotime Revenue (2020-2025) & (US$ Million)
 Table 136. Beyotime Recent Development
 Table 137. General Biol Company Details
 Table 138. General Biol Business Overview
 Table 139. General Biol Oligo Synthesis Product
 Table 140. General Biol Revenue (2020-2025) & (US$ Million)
 Table 141. General Biol Recent Development
 Table 142. Biosune Company Details
 Table 143. Biosune Business Overview
 Table 144. Biosune Oligo Synthesis Product
 Table 145. Biosune Revenue (2020-2025) & (US$ Million)
 Table 146. Biosune Recent Development
 Table 147. Research Programs/Design for This Report
 Table 148. Key Data Information from Secondary Sources
 Table 149. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global Oligo Synthesis Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 2. Global Oligo Synthesis Market Share by Type: 2024 VS 2031
 Figure 3. Common Primer Synthesis Features
 Figure 4. Modified Primer Synthesis Features
 Figure 5. Global Oligo Synthesis Market Size Growth Rate by End User, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Global Oligo Synthesis Market Share by End User: 2024 VS 2031
 Figure 7. Biotech Company Case Studies
 Figure 8. Academic Scientific Research Institution Case Studies
 Figure 9. Oligo Synthesis Report Years Considered
 Figure 10. Global Oligo Synthesis Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 11. Global Oligo Synthesis Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Oligo Synthesis Market Share by Region: 2024 VS 2031
 Figure 13. Global Oligo Synthesis Market Share by Players in 2024
 Figure 14. Global Top Oligo Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligo Synthesis as of 2024)
 Figure 15. The Top 10 and 5 Players Market Share by Oligo Synthesis Revenue in 2024
 Figure 16. North America Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 17. North America Oligo Synthesis Market Share by Type (2020-2031)
 Figure 18. North America Oligo Synthesis Market Share by End User (2020-2031)
 Figure 19. North America Oligo Synthesis Market Share by Country (2020-2031)
 Figure 20. United States Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Oligo Synthesis Market Share by Type (2020-2031)
 Figure 24. Europe Oligo Synthesis Market Share by End User (2020-2031)
 Figure 25. Europe Oligo Synthesis Market Share by Country (2020-2031)
 Figure 26. Germany Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. China Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. China Oligo Synthesis Market Share by Type (2020-2031)
 Figure 34. China Oligo Synthesis Market Share by End User (2020-2031)
 Figure 35. Asia Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia Oligo Synthesis Market Share by Type (2020-2031)
 Figure 37. Asia Oligo Synthesis Market Share by End User (2020-2031)
 Figure 38. Asia Oligo Synthesis Market Share by Region (2020-2031)
 Figure 39. Japan Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. India Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Australia Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East, Africa, and Latin America Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East, Africa, and Latin America Oligo Synthesis Market Share by Type (2020-2031)
 Figure 47. Middle East, Africa, and Latin America Oligo Synthesis Market Share by End User (2020-2031)
 Figure 48. Middle East, Africa, and Latin America Oligo Synthesis Market Share by Country (2020-2031)
 Figure 49. Brazil Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Mexico Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Turkey Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Israel Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. GCC Countries Oligo Synthesis Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 56. Merck Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 57. Azenta Life Sciences Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 58. BBI Life Sciences Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 59. TriLink BioTechnologies Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 60. Aurigene Pharmaceutical Services Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 61. Integrated DNA Technologies (IDT) Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 62. Cusabio Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 63. Macrogen Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 64. Synbio Technologies Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 65. Eurogentec Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 66. Genscript Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 67. Abace Biotechnology Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 68. Tsingke Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 69. Guangzhou RiboBio Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 70. Atantares Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 71. Wuhan GeneCreate Biological Engineering Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 72. Beyotime Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 73. General Biol Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 74. Biosune Revenue Growth Rate in Oligo Synthesis Business (2020-2025)
 Figure 75. Bottom-up and Top-down Approaches for This Report
 Figure 76. Data Triangulation
 Figure 77. Key Executives Interviewed